SOBRsafe Inc. (NASDAQ: SOBR), a provider of next-generation alcohol detection technology, has entered into definitive agreements for the immediate exercise of certain outstanding warrants at a reduced exercise price of $1.05 per share. The transaction is expected to generate gross proceeds of approximately $3.1 million before fees and expenses, according to a press release from NetworkNewsWire. In connection with the offering, the company will issue new unregistered Series E and Series F warrants to purchase an aggregate of 4.7 million shares. The offering is expected to close on or about July 16, 2026, with net proceeds designated for working capital and general corporate purposes. H.C. Wainwright & Co. is serving as the exclusive placement agent.
This capital infusion comes as SOBRsafe continues to commercialize its transdermal alcohol detection technology, which detects alcohol emitted through the skin in real time without requiring breath, blood, or urine samples. The company's solutions target behavioral health, family law, and consumer markets, as well as licensing and integration opportunities. The additional funds are likely to accelerate product development, expand sales and marketing efforts, and support operational scaling. For investors, this move demonstrates management's ability to raise capital while minimizing dilution through the use of warrant exercises, albeit at a reduced price. The new warrants also provide potential upside for investors if the stock performs well.
The transaction underscores the company's commitment to strengthening its balance sheet amid a competitive landscape for alcohol monitoring technologies. SOBRsafe's touch-based system offers a passive and dignified alternative to traditional methods, which could drive adoption in court-ordered monitoring and workplace safety programs. The company's backend data platform provides real-time reporting and analytics, adding value for institutional clients. However, the company faces challenges in market penetration and revenue generation, making this capital raise critical for sustaining operations until it achieves profitability. The involvement of H.C. Wainwright & Co. as placement agent lends credibility to the offering and may attract institutional interest.
For more information about SOBRsafe, visit www.sobrsafe.com. The latest news and updates are available in the company's newsroom at https://nnw.fm/SOBR.
